1 September 2024

OTCQX Life Sciences Presentation

Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced that as part of its OTCQX  investor communications, a pre-recorded presentation by Chief Executive Officer Dr Jackie Fairley will be broadcast at VirtualInvestorConferences.com on Thursday, October 1, 2015 at 12.15pm (EDT time). The presentation is part of a special OTCQX Life Sciences virtual Conference.

 

The presentation will provide an overview of the Company for new investors including recent announcements:

 

  • EU marketing approval for VivaGel® BV; and
  • Drug delivery license with AstraZeneca for DEP™ technology.

 

Interested parties are able to register at www.virtualinvestorconferences.com or at the following link: http://tinyurl.com/101pre .  An on-demand archive will be available for 90 days at www.virtualinvestorconferences.com.   

 

A copy of the presentation slides is below.

 

Download ASX Announcement: OTCQX Life Sciences Presentation (pdf file, 990kb)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.